Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($) $ in Thousands |
Dec. 31, 2025 |
Dec. 31, 2024 |
|---|---|---|
| Deferred tax assets: | ||
| Capitalized research and development costs | $ 29,024 | $ 38,850 |
| Net operating loss carryforwards | 27,713 | 1,436 |
| Orphan drug credit carryforwards | 7,448 | 2,193 |
| Research and development credit carryforwards | 1,326 | 422 |
| Intangible assets | 2,848 | 2,705 |
| Accrued expenses and other | 8,298 | 6,760 |
| Operating lease liability | 1,703 | 2,287 |
| Gross deferred tax assets | 78,360 | 54,653 |
| Valuation allowance | (76,506) | (51,753) |
| Net deferred tax assets | 1,854 | 2,900 |
| Deferred tax liability | (1,854) | (2,900) |
| Net deferred tax assets | $ 0 | $ 0 |
| X | ||||||||||
- Definition Deferred tax assets, capitalized research and development costs. No definition available.
|
| X | ||||||||||
- Definition Deferred Tax Assets, Operating lease Liabilities No definition available.
|
| X | ||||||||||
- Definition Deferred tax assets orphan drug credit carryforwards. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|